NCT Number: NCT06347705
Phase: PHASE2
Trial Summary: The purpose of this study is to see whether combining 2141-V11 with various standard treatments is an effective treatment approach for prostate cancer. 2141-V11 works by activating the immune system t – clinicaltrials.gov for more information and locations
Clinicaltrials.gov
Trial Sponsor(s): MidLantic Urology
Acronym:
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
— PHENTrials.com Increasing Participation in Prostate Cancer Clinical Trials to Save Lives